Predictive Oncology Inc.

NASDAQ:POAI

1.4 (USD) • At close April 2, 2025
Bedrijfsnaam Predictive Oncology Inc.
Symbool POAI
Munteenheid USD
Prijs 1.4
Beurswaarde 10,093,580
Dividendpercentage 0%
52-weken bereik 0.55 - 3.06
Industrie Medical Instruments & Supplies
Sector Healthcare
CEO Mr. Raymond F. Vennare
Website https://www.predictive-oncology.com

An error occurred while fetching data.

Over Predictive Oncology Inc.

Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States. The company operates in four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment offers clinical testing services comprising tumor drug response testing and genomic profiling tests; and contract

Vergelijkbare Aandelen

GeoVax Labs, Inc. logo

GeoVax Labs, Inc.

GOVX

1.18 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)